======= MED13L ======= == Gene Information == * **Official Symbol**: MED13L * **Official Name**: mediator complex subunit 13L * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23389|23389]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q71F56|Q71F56]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MED13L&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MED13L|Open PubMed]] * **OMIM**: [[https://omim.org/entry/608771|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene is a subunit of the Mediator complex, a large complex of proteins that functions as a transcriptional coactivator for most RNA polymerase II-transcribed genes. The encoded protein is involved in early development of the heart and brain. Defects in this gene are a cause of transposition of the great arteries, dextro-looped (DTGA).[provided by RefSeq, Jul 2010]. * **UniProt Summary**: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. This subunit may specifically regulate transcription of targets of the Wnt signaling pathway and SHH signaling pathway. |Med13 N| |Med13 C| |mediator complex| |transcription coregulator activity| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp444|THZ531 0.225μM R08 exp444]]|-1.76| |[[:results:exp96|BI-2536 0.02μM R03 exp96]]|1.71| |[[:results:exp84|UM0125461 0.74μM R02 exp84]]|1.71| |[[:results:exp443|SNS-032 15μM R08 exp443]]|1.74| |[[:results:exp147|Resveratrol 16μM R03 exp147]]|1.76| |[[:results:exp130|JQ1 0.01μM R03 exp130]]|1.8| |[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|1.82| |[[:results:exp59|UMK57 1μM R01 exp59]]|1.86| |[[:results:exp141|Nifurtimox 1μM R03 exp141]]|2.02| |[[:results:exp128|GSK591 2.6μM R03 exp128]]|2.09| |[[:results:exp108|Vinblastine 0.2μM R03 exp108]]|2.25| |[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|2.36| |[[:results:exp103|Taxol 0.004μM R03 exp103]]|2.74| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|2.87| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|3.09| |[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|3.21| ^Gene^Correlation^ |[[:human genes:m:med13|MED13]]|0.67| |[[:human genes:z:znf592|ZNF592]]|0.551| |[[:human genes:b:brpf1|BRPF1]]|0.55| |[[:human genes:t:tada2b|TADA2B]]|0.55| |[[:human genes:s:supt7l|SUPT7L]]|0.539| |[[:human genes:t:taf5l|TAF5L]]|0.535| |[[:human genes:m:mllt1|MLLT1]]|0.52| |[[:human genes:t:taf6l|TAF6L]]|0.516| |[[:human genes:i:ing5|ING5]]|0.51| |[[:human genes:c:ccnc|CCNC]]|0.508| |[[:human genes:f:fbxo11|FBXO11]]|0.506| |[[:human genes:h:hdac8|HDAC8]]|0.505| |[[:human genes:a:aff1|AFF1]]|0.5| |[[:human genes:m:med23|MED23]]|0.5| |[[:human genes:z:zc3h18|ZC3H18]]|0.496| |[[:human genes:m:med10|MED10]]|0.489| |[[:human genes:t:tada3|TADA3]]|0.485| |[[:human genes:k:khdrbs1|KHDRBS1]]|0.475| |[[:human genes:d:dek|DEK]]|0.473| |[[:human genes:d:dcaf7|DCAF7]]|0.469| |[[:human genes:t:thoc6|THOC6]]|0.468| |[[:human genes:u:ube2g1|UBE2G1]]|0.463| |[[:human genes:t:tada1|TADA1]]|0.454| |[[:human genes:c:clk3|CLK3]]|0.454| |[[:human genes:u:ubr5|UBR5]]|0.448| |[[:human genes:t:tceb3|TCEB3]]|0.448| |[[:human genes:m:med7|MED7]]|0.447| |[[:human genes:p:prr12|PRR12]]|0.446| |[[:human genes:a:atxn7|ATXN7]]|0.443| |[[:human genes:d:dcaf5|DCAF5]]|0.443| |[[:human genes:e:ehmt2|EHMT2]]|0.442| |[[:human genes:v:vcpip1|VCPIP1]]|0.424| |[[:human genes:m:max|MAX]]|0.424| |[[:human genes:k:kat2a|KAT2A]]|0.423| |[[:human genes:a:actb|ACTB]]|0.422| |[[:human genes:c:ctdspl2|CTDSPL2]]|0.422| |[[:human genes:p:prkar1a|PRKAR1A]]|0.422| |[[:human genes:z:zranb1|ZRANB1]]|0.42| |[[:human genes:m:mllt10|MLLT10]]|0.416| |[[:human genes:c:csrnp1|CSRNP1]]|0.415| |[[:human genes:s:sirt7|SIRT7]]|0.414| |[[:human genes:w:wdr24|WDR24]]|0.414| |[[:human genes:p:pus10|PUS10]]|0.413| |[[:human genes:c:ccdc101|CCDC101]]|0.411| |[[:human genes:h:hhex|HHEX]]|0.409| |[[:human genes:f:fnip1|FNIP1]]|0.406| |[[:human genes:m:med25|MED25]]|0.404| |[[:human genes:f:fli1|FLI1]]|0.401| Global Fraction of Cell Lines Where Essential: 1/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|1/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1664 * **Expression level (log2 read counts)**: 6.42 {{:chemogenomics:nalm6 dist.png?nolink |}}